
Patients lose an averageof 15% of their body weight¹
Based on a 68-week clinical study of once-weekly injection of a GLP-1 receptor agonist compared to a placebo with 1961 participants.
https://www.nejm.org/doi/full/10.1056/NEJMoa2032183
Get Started